Cited by 601Chemokine receptors and signalingNeuroinflammation and Neurodegeneration MechanismsAtherosclerosis and Cardiovascular Diseases

The DOI matches its Crossref record; 46 of the 46 references it cites were found in a registry or an index.

Selective Chemokine Receptor Usage by Central Nervous System Myeloid Cells in CCR2-Red Fluorescent Protein Knock-In Mice

Open access

Abstract

BACKGROUND: Monocyte subpopulations distinguished by differential expression of chemokine receptors CCR2 and CX3CR1 are difficult to track in vivo, partly due to lack of CCR2 reagents. METHODOLOGY/PRINCIPAL FINDINGS: We created CCR2-red fluorescent protein (RFP) knock-in mice and crossed them with CX3CR1-GFP mice to investigate monocyte subset trafficking. In mice with experimental autoimmune encephalomyelitis, CCR2 was critical for efficient intrathecal accumulation and localization of Ly6C(hi)/CCR2(hi) monocytes. Surprisingly, neutrophils, not Ly6C(lo) monocytes, largely replaced Ly6C(hi) cells in the central nervous system of these mice. CCR2-RFP expression allowed the first unequivocal distinction between infiltrating monocytes/macrophages from resident microglia. CONCLUSION/SIGNIFICANCE: These results refine the concept of monocyte subsets, provide mechanistic insight about monocyte entry into the central nervous system, and present a novel model for imaging and quantifying inflammatory myeloid populations.

Overview

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1371/journal.pone.0013693

Cites

46 of 46 references verified0 citation errors · 0 not checkable

Statistics

Figures

Figure 1 Generation and characterization of CCR2RFP mice. (A) Recombinant targeting strategy. Hatched box represents region of CCR2 deleted by recombination. Triangles represent loxP sites. (B) Southern blot analysis of WT, Ccr2RFP/+ heterozygous, and Ccr2RFP/RFP homozygous genomic DNA. DNA was digested with PstI, and hybridized with the indicated probe. (C) Flow cytometry analysis of peripheral blood leukocytes (PBL) from WT, Ccr2RFP/+, and Ccr2RFP/RFP mice. Cells were stained with anti-CCR2 antibody MC21. The results are representative of four similar experiments.
Figure 1 Generation and characterization of CCR2RFP mice. (A) Recombinant targeting strategy. Hatched box represents region of CCR2 deleted by recombination. Triangles represent loxP sites. (B) Southern blot analysis of WT, Ccr2RFP/+ heterozygous, and Ccr2RFP/RFP homozygous genomic DNA. DNA was digested with PstI, and hybridized with the indicated probe. (C) Flow cytometry analysis of peripheral blood leukocytes (PBL) from WT, Ccr2RFP/+, and Ccr2RFP/RFP mice. Cells were stained with anti-CCR2 antibody MC21. The results are representative of four similar experiments.CC BY · PubMed Central
Figure 2 Expression of CCR2 and RFP in sorted cell populations. (A) CD115+ monocytes were sorted by flow cytometry into populations that did or did not express cell-surface CCR2. Total RNA was isolated, pooled from three mice per genotype, and analyzed for CCR2 mRNA and RFP mRNA by quantitative RT-PCR. Probe specificity was confirmed with WT and Ccr2−/− cells. Expression levels were normalized to beta-actin, and the results are expressed relative to the concentration of CCR2 mRNA in monocytes expressing cell-surface CCR2. (B) NK and T cells were sorted by flow cytometry into RFP+ and RFP– fractions. Expression of CCR2 and RFP mRNA was characterized as in (A) and normalized to the amount of CCR2 RNA in the RFP+ T-cell fraction from Ccr2+/RFP mice. (C to G) WT, Ccr2RFP/+, and Ccr2RFP/RFP mice were bred onto the Apoe−/− background and fed a high-fat diet for 8 weeks. Peripheral blood monocytes were stained for CD115, CCR2, and Ly6C and analyzed by flow cytometry. (C) Gating on monocytes. (D) Ly6C and RFP expression of monocytes. Dashed line indicates the cutoff for a positive RFP signal. (E) Mean RFP fluorescence intensity in Ly6Chi and Ly6Clo subsets. Bars indicate SEM. n = 4 mice/group. P<0.008. (F) CCR2 and RFP expression of Ly6Chi monocytes. (G) CCR2 and RFP expression in Ly6Clo monocytes. CCR2-positive and CCR2-negative gates were based on CCR2-deficient Ccr2RFP/RFP mice. (H to K) Flow cytometric analysis of Ly6C, RFP, GFP and cell-surface CCR2 expression on monocytes from Ccr2RFP/+Cx3cr1GFP/+ mice. CD115+ monocytes were gated (H) by Ly6C/GFP expression and analyzed for RFP (I) and CCR2 (J) expression. Ccr2RFP/RFPCx3cr1GFP/+ monocytes (K) were used as a negative control for CCR2 surface-staining. Results are representative of four mice in two similar experiments.
Figure 2 Expression of CCR2 and RFP in sorted cell populations. (A) CD115+ monocytes were sorted by flow cytometry into populations that did or did not express cell-surface CCR2. Total RNA was isolated, pooled from three mice per genotype, and analyzed for CCR2 mRNA and RFP mRNA by quantitative RT-PCR. Probe specificity was confirmed with WT and Ccr2−/− cells. Expression levels were normalized to beta-actin, and the results are expressed relative to the concentration of CCR2 mRNA in monocytes expressing cell-surface CCR2. (B) NK and T cells were sorted by flow cytometry into RFP+ and RFP– fractions. Expression of CCR2 and RFP mRNA was characterized as in (A) and normalized to the amount of CCR2 RNA in the RFP+ T-cell fraction from Ccr2+/RFP mice. (C to G) WT, Ccr2RFP/+, and Ccr2RFP/RFP mice were bred onto the Apoe−/− background and fed a high-fat diet for 8 weeks. Peripheral blood monocytes were stained for CD115, CCR2, and Ly6C and analyzed by flow cytometry. (C) Gating on monocytes. (D) Ly6C and RFP expression of monocytes. Dashed line indicates the cutoff for a positive RFP signal. (E) Mean RFP fluorescence intensity in Ly6Chi and Ly6Clo subsets. Bars indicate SEM. n = 4 mice/group. P<0.008. (F) CCR2 and RFP expression of Ly6Chi monocytes. (G) CCR2 and RFP expression in Ly6Clo monocytes. CCR2-positive and CCR2-negative gates were based on CCR2-deficient Ccr2RFP/RFP mice. (H to K) Flow cytometric analysis of Ly6C, RFP, GFP and cell-surface CCR2 expression on monocytes from Ccr2RFP/+Cx3cr1GFP/+ mice. CD115+ monocytes were gated (H) by Ly6C/GFP expression and analyzed for RFP (I) and CCR2 (J) expression. Ccr2RFP/RFPCx3cr1GFP/+ monocytes (K) were used as a negative control for CCR2 surface-staining. Results are representative of four mice in two similar experiments.CC BY · PubMed Central
Figure 3 Analysis of peritoneal exudate cells from Ccr2-RFP Cx3cr1-GFP mice in a sterile peritonitis model. WT, Ccr2RFP/+Cx3cr1GFP/+, Ccr2RFP/+Cxc3r1GFP/GFP, Ccr2RFP/RFPCx3cr1GFP/+, and Ccr2RFP/RFPCx3cr1GFP/GFP mice were injected intraperitoneally with thioglycollate, and inflammatory exudate cells were harvested 24 h later. Cells were stained with F4/80. (A) RFP/GFP profiles of F4/80+ peritoneal cells from naive mice (top panels) and 24 hr after injection (bottom panels). (B) Percentage of exudate cells staining positive for F4/80. Values are mean ± SEM. n = 4 mice/group. Results are representative of two similar experiments.
Figure 3 Analysis of peritoneal exudate cells from Ccr2-RFP Cx3cr1-GFP mice in a sterile peritonitis model. WT, Ccr2RFP/+Cx3cr1GFP/+, Ccr2RFP/+Cxc3r1GFP/GFP, Ccr2RFP/RFPCx3cr1GFP/+, and Ccr2RFP/RFPCx3cr1GFP/GFP mice were injected intraperitoneally with thioglycollate, and inflammatory exudate cells were harvested 24 h later. Cells were stained with F4/80. (A) RFP/GFP profiles of F4/80+ peritoneal cells from naive mice (top panels) and 24 hr after injection (bottom panels). (B) Percentage of exudate cells staining positive for F4/80. Values are mean ± SEM. n = 4 mice/group. Results are representative of two similar experiments.CC BY · PubMed Central
Figure 4 CCR2-deficient mice exhibit delayed onset EAE and decreased monocyte recruitment to the CNS. (A) Ccr2RFP/+Cx3cr1GFP/+ and Ccr2RFP/RFPCx3cr1GFP/+ mice were immunized with MOG peptide 33–55 and scored daily for neurological signs. (B) EAE symptom onset and peak disease. (C) Total number of brain mononuclear cells and CD45hi infiltrating cells at peak disease. (D) CD45hi infiltrating cells were analyzed to quantify total neutrophils (SSChi, CD115−, Ly6Clo), monocytes (CD115+), and monocyte subsets (CD115+/Ly6Chi/lo), (E) CX3CR1 GFP and CCR2-RFP fluorescence intensities in monocyte subsets and microglia. Data points represent individual mice. Values are mean ± SEM. Results are representative of two similar experiments.
Figure 4 CCR2-deficient mice exhibit delayed onset EAE and decreased monocyte recruitment to the CNS. (A) Ccr2RFP/+Cx3cr1GFP/+ and Ccr2RFP/RFPCx3cr1GFP/+ mice were immunized with MOG peptide 33–55 and scored daily for neurological signs. (B) EAE symptom onset and peak disease. (C) Total number of brain mononuclear cells and CD45hi infiltrating cells at peak disease. (D) CD45hi infiltrating cells were analyzed to quantify total neutrophils (SSChi, CD115−, Ly6Clo), monocytes (CD115+), and monocyte subsets (CD115+/Ly6Chi/lo), (E) CX3CR1 GFP and CCR2-RFP fluorescence intensities in monocyte subsets and microglia. Data points represent individual mice. Values are mean ± SEM. Results are representative of two similar experiments.CC BY · PubMed Central
Figure 5 Expression of CX3CR1 and CCR2 in brain lesions of mice with EAE. (A–C) Low-magnification epifluorescence images of naive Ccr2RFP/+Cx3cr1GFP/+ (A), diseased Ccr2RFP/+Cx3cr1GFP/+ (B), and Ccr2RFP/RFPCx3cr1GFP/+ (C) brains show the extent of inflammation and anatomical location of the lesions. Higher magnification views of the boxed areas are shown in panels D–F. Confocal image of healthy perivascular (D) tissue shows GFP+ microglia (asterisks), small round RFP+ cells (arrowhead), and double-positive cells (circles). (E) Parenchymal lesion in a Ccr2RFP/+Cx3cr1GFP/+mouse and (F) a perivascular lesion from a Ccr2RFP/RFPCx3cr1GFP/+ mouse at peak EAE disease. Dashed line in (F) indicates the approximate perivascular boundary. Within EAE lesions, note RFP/GFP double-positive cells (circles), GFP+ activated microglia (E, F; asterisks), large elongated RFP+ cells (E, F; arrows), and small round RFP+ cells (E, F; arrowheads). Small RFP+ cells were CD3+ (not shown). The particularly elongated RFP+ cells in the Ccr2RFP/+Cx3cr1GFP/+ lesion (E) were much less abundant in the Ccr2RFP/RFPCx3cr1GFP/+ lesion (F).
Figure 5 Expression of CX3CR1 and CCR2 in brain lesions of mice with EAE. (A–C) Low-magnification epifluorescence images of naive Ccr2RFP/+Cx3cr1GFP/+ (A), diseased Ccr2RFP/+Cx3cr1GFP/+ (B), and Ccr2RFP/RFPCx3cr1GFP/+ (C) brains show the extent of inflammation and anatomical location of the lesions. Higher magnification views of the boxed areas are shown in panels D–F. Confocal image of healthy perivascular (D) tissue shows GFP+ microglia (asterisks), small round RFP+ cells (arrowhead), and double-positive cells (circles). (E) Parenchymal lesion in a Ccr2RFP/+Cx3cr1GFP/+mouse and (F) a perivascular lesion from a Ccr2RFP/RFPCx3cr1GFP/+ mouse at peak EAE disease. Dashed line in (F) indicates the approximate perivascular boundary. Within EAE lesions, note RFP/GFP double-positive cells (circles), GFP+ activated microglia (E, F; asterisks), large elongated RFP+ cells (E, F; arrows), and small round RFP+ cells (E, F; arrowheads). Small RFP+ cells were CD3+ (not shown). The particularly elongated RFP+ cells in the Ccr2RFP/+Cx3cr1GFP/+ lesion (E) were much less abundant in the Ccr2RFP/RFPCx3cr1GFP/+ lesion (F).CC BY · PubMed Central
Figure 6 Analysis of monocyte subsets in brain lesions of EAE Ccr2RFP/+Cx3cr1GFP/+ mice at peak EAE. Confocal images of the periventricular lesions were obtained after staining with the 7/4 antibody. Images represent the same lesion (A) Merged images of red/CCR2, green/CX3CR1, and blue/7/4. (B) Red/CCR2 and green/CX3CR1. (C) Blue/7/4 and green/CX3CR1. (D) Red/CCR2 and blue/7/4. The majority of CCR2+ cells are 7/4+ and CX3CR1lo or negative, suggesting that they are classical infiltrating monocytes (see individual cell “1”). Ly6Clo monocytes (CX3CR1hi and CCR2) are also present (cell “2”), as well as T cells (“3”) and activated microglial cells (“4”).
Figure 6 Analysis of monocyte subsets in brain lesions of EAE Ccr2RFP/+Cx3cr1GFP/+ mice at peak EAE. Confocal images of the periventricular lesions were obtained after staining with the 7/4 antibody. Images represent the same lesion (A) Merged images of red/CCR2, green/CX3CR1, and blue/7/4. (B) Red/CCR2 and green/CX3CR1. (C) Blue/7/4 and green/CX3CR1. (D) Red/CCR2 and blue/7/4. The majority of CCR2+ cells are 7/4+ and CX3CR1lo or negative, suggesting that they are classical infiltrating monocytes (see individual cell “1”). Ly6Clo monocytes (CX3CR1hi and CCR2) are also present (cell “2”), as well as T cells (“3”) and activated microglial cells (“4”).CC BY · PubMed Central

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 46 references

Cited by

Sorted by citations

Metadata

Authors
Saederup, N., Cardona, A. E., Croft, K., Mizutani, M., Cotleur, A. C., Tsou, C.-L., Ransohoff, R. M., & Charo, I. F.
Affiliations
  • Gladstone Institutes (US)
  • Cleveland Clinic (US)
Corresponding author
  • Ransohoff, Richard M.
  • Charo, Israel F.
Venue
PLoS ONE
Published
2010-10-27
Volume
5
Issue
10
Pages
e13693
ISSN
1932-6203 (ISSN-L)
OpenAlex
W2104003768
Cited by
599
References
46
Citations by year
2026: 19 · 2025: 28 · 2024: 60 · 2023: 32 · 2022: 22 · 2021: 38 · 2020: 49 · 2019: 54 · 2018: 42 · 2017: 51 · 2016: 44 · 2015: 49 · 2014: 46 · 2013: 30 · 2012: 17
FWCI
9.81
Type
journal article
Language
en
Open access
Locations
  • PLoS ONE (publishedVersion, cc-by)
  • PubMed Central (publishedVersion, cc-by)
  • PubMed (publishedVersion)
  • DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
  • Figshare (submittedVersion, cc-by)
Funders
  • National Multiple Sclerosis Society
  • Multiple Sclerosis Society
  • National Institutes of Health
  • National Heart, Lung, and Blood Institute (R01HL063894, R01HL052773, HL 52773, HL63894)
  • National Institute of Neurological Disorders and Stroke (R01NS32151, R01NS032151)
Topics
  • Health Sciences › Medicine › Oncology › Chemokine receptors and signaling
  • Life Sciences › Neuroscience › Neurology › Neuroinflammation and Neurodegeneration Mechanisms
  • Life Sciences › Immunology and Microbiology › Immunology › Atherosclerosis and Cardiovascular Diseases
Keywords
CCR2, CX3CR1, monocyte subsets, monocyte trafficking, experimental autoimmune encephalomyelitis, Ly6C, neutrophils, microglia, red fluorescent protein
MeSH terms
Red Fluorescent Protein, Animals, Central Nervous System, Luminescent Proteins, Mice, Receptors, CCR2

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review